BCAT1 and nonpapillary renal cell carcinoma: BCAT1 exhibited strong predictive value in ccRCC patients (Figure 6A) and was associated with poor Progress Free Interval (PFI) and Disease-Specific Survival (DSS) (Figure 6B, 6C).